[Business Wire] - BioCryst Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock, offered at a price to the public of $4.40 per share.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment